Biogen (BIIB) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free biib Stock Alerts $209.02 +6.56 (+3.24%) (As of 03:59 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline6,103 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Alaska Permanent Fund Corpmarketbeat.com - April 26 at 9:40 AMBiogen Inc. Expected to Post Q2 2024 Earnings of $4.24 Per Share (NASDAQ:BIIB)marketbeat.com - April 26 at 8:49 AMBiogen’s Surpassing Performance and Positive Outlook Affirm Buy Ratingmarkets.businessinsider.com - April 26 at 7:44 AMBuy Rating Justified: Biogen’s Promising Drug Launches and Strategic Growth Initiativesmarkets.businessinsider.com - April 26 at 7:44 AMBiogen Q1 Earnings Transcriptmarketbeat.com - April 26 at 7:03 AMNeedham & Company LLC Reiterates Buy Rating for Biogen (NASDAQ:BIIB)americanbankingnews.com - April 26 at 3:44 AMBiogen cost cuts drive profit beat, as Alzheimer's drug off to slow startmsn.com - April 26 at 2:44 AMDecoding Biogen Inc (BIIB): A Strategic SWOT Insightfinance.yahoo.com - April 26 at 2:44 AMBiogen Inc.: Biogen Receives Positive CHMP Opinion for TOFIDENCE (tocilizumab), a Biosimilar Referencing ROACTEMRA®finanznachrichten.de - April 25 at 4:43 PMBiogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcriptmsn.com - April 25 at 4:43 PMBiogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®globenewswire.com - April 25 at 4:05 PMBiogen (NASDAQ:BIIB) Price Target Cut to $200.00marketbeat.com - April 25 at 2:29 PMBiogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Whymsn.com - April 25 at 11:37 AMThese Analysts Revise Their Forecasts On Biogen After Q1 Resultsbenzinga.com - April 25 at 11:37 AMJefferies Keeps Their Buy Rating on Biogen (BIIB)markets.businessinsider.com - April 25 at 11:37 AMQ1 2024 Biogen Inc Earnings Callfinance.yahoo.com - April 25 at 11:37 AMFor Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Dofinance.yahoo.com - April 25 at 11:37 AMShareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past yearfinance.yahoo.com - April 25 at 11:37 AMBiogen (NASDAQ:BIIB) Announces Quarterly Earnings Resultsmarketbeat.com - April 25 at 11:20 AMWedbush Boosts Biogen (NASDAQ:BIIB) Price Target to $215.00marketbeat.com - April 25 at 9:18 AMCalifornia Public Employees Retirement System Raises Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 25 at 7:48 AMLatest Biogen Inc (BIIB) SEC 10-Q Filing: Decoding Their Quarterly Performanceamericanbankingnews.com - April 25 at 2:10 AMWhy Biogen Stock Leaped Nearly 5% Higher Todayfool.com - April 24 at 6:18 PMBiogen (NASDAQ:BIIB) Sees Strong Trading Volumemarketbeat.com - April 24 at 3:36 PMBiogen (BIIB) Q1 2024 Earnings Call Transcriptmsn.com - April 24 at 3:32 PMBiogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earningsfinance.yahoo.com - April 24 at 3:32 PMBIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024investorplace.com - April 24 at 12:11 PMBiogen (NASDAQ:BIIB) Issues FY 2024 Earnings Guidancemarketbeat.com - April 24 at 10:43 AMBiogen Affirms Guidance After Mixed First Quartermsn.com - April 24 at 10:31 AMBiogen cost cuts drive profit beat, Alzheimer's drug sales jumpfinance.yahoo.com - April 24 at 10:31 AMBiogen Inc (BIIB) Q1 2024 Earnings: Mixed Results Amidst Strategic Growth Effortsfinance.yahoo.com - April 24 at 10:31 AMAlzheimer’s Drug Leqembi Finally Sees Sales Pickupfinance.yahoo.com - April 24 at 10:31 AMBiogen Stock Rises After Earnings and on Jump in Alzheimer’s Drug Salesfinance.yahoo.com - April 24 at 10:31 AMBiogen Beats Estimates as Alzheimer’s Drug Gains Tractionfinance.yahoo.com - April 24 at 10:31 AMBiogen Stock Surges After Two Notable Products Walloped Sales Expectationsfinance.yahoo.com - April 24 at 10:31 AMBiogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improvesmarketwatch.com - April 24 at 9:01 AMBiogen Stock Rises After Earnings and on Jump in Alzheimer's Drug Salesbarrons.com - April 24 at 8:51 AMBiogen's (BIIB) Buy Rating Reaffirmed at Needham & Company LLCmarketbeat.com - April 24 at 8:43 AMBiogen says uptake for Alzheimer’s therapy is improvingseekingalpha.com - April 24 at 8:15 AMBiogen beats quarterly profit estimates, Alzheimer's drug sales jumpreuters.com - April 24 at 6:48 AMHandelsbanken Fonder AB Has $14.89 Million Stake in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 24 at 6:48 AMBiogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks upcnbc.com - April 24 at 6:47 AMIllinois Municipal Retirement Fund Has $12.71 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 23 at 1:03 PMInsight: Alzheimer's drug adoption in US slowed by doctors' skepticismreuters.com - April 23 at 9:21 AMBiogen Inc. (NASDAQ:BIIB) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 23 at 2:20 AMBiogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - April 23 at 2:13 AMShould You Be Confident in Biogen (BIIB)?finance.yahoo.com - April 23 at 1:12 AMWedge Capital Management L L P NC Has $32.99 Million Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 22 at 6:07 PMabrdn plc Has $113.10 Million Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 21 at 9:22 AMOppenheimer Lowers Biogen (NASDAQ:BIIB) Price Target to $270.00americanbankingnews.com - April 21 at 4:52 AM Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. BIIB Media Mentions By Week BIIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.390.33▲Average Medical News Sentiment BIIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼7417▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: American Electric Power News Today Neurocrine Biosciences News Today Repligen News Today Pinnacle West Capital News Today CRISPR Therapeutics News Today Portland General Electric News Today Denali Therapeutics News Today Gilead Sciences News Today argenx News Today BioNTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
